Ranked 30th on Forbes list of 2015(2015-01-16)
PW Medtech Ranked 30th on Forbes list of
2015 China’s Listed Potential Enterprise Top 100
[16 January 2015, Hong Kong] PW Medtech Group Limited (“PW Medtech” or the “Company” and, together with its subsidiaries, the “Group”; stock code: 1358), a leading medical device company in China, is pleased to announce that for the first time the Company was listed on Forbes' “China’s Listed Potential Enterprise Top 100” list and ranked 30th.
Forbes’s Potential Enterprise List was honored as “Indicator of Growth” in industrial and investment fields in China every year, including 100 listed enterprise and non-listed enterprise with high growth potential. Forbes researched and selected the middle and small size enterprises with the 2013 revenue between RMB10 million and RMB1 billion and major business in China mainland, then ranked them according to below judging principles, such us growth indicator (growth of revenue and net profit), profitability indicator (profit margin), investment return indicator (ROA and ROE) and scale indicator (scale of revenue and net profit).
Mr Jiang Liwei, Chief Executive Officer of PW Medtech said, “Being shortlisted in the Forbes list of China’s Listed Potential Enterprise Top 100 has proven a strong recognition to PW Medtech’s outstanding results and growth potential. The Group’s business has penetrated in research, production and distribution of regenerative medical biological materials, orthopedic implants and advanced infusion sets products. Going forward, we will continue to achieve rapid growth of our existing principal business. With our proven acquisition and integration capabilities, we will further increase market shares in medical devices industry, achieving the Group’s sustainable business development.”